Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS ) 22.39 -1.63 (-6.79%) Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about GeneDx Holdings Corp. - Class A Common Stock < Previous 1 2 3 4 Next > Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying May 16, 2024 Via Benzinga Gold Down Over 2%; 3M Profit Beats Expectations April 30, 2024 Via Benzinga Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 30, 2024 Via Benzinga Earnings Preview: GeneDx Hldgs February 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 30, 2024 Via Benzinga Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday April 30, 2024 Via Benzinga Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 30, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 30, 2024 Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today! Via InvestorPlace WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q1 2024 April 29, 2024 WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance April 29, 2024 GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%. The company reported quarterly sales of $62.422 million which beat the... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session April 29, 2024 Via Benzinga GeneDx Reports First Quarter 2024 Financial Results and Business Highlights April 29, 2024 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset April 23, 2024 The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 April 04, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 19, 2024 Via Benzinga GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics March 14, 2024 From GeneDx Holdings Corp. Via GlobeNewswire Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 18, 2024 Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates. Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session March 08, 2024 Via Benzinga GeneDx to Participate in 44th Annual Cowen Health Care Conference February 26, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's After-Market Session February 22, 2024 Via Benzinga GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024 February 20, 2024 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 February 01, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session January 25, 2024 Via Benzinga Earnings Scheduled For February 20, 2024 February 20, 2024 Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. Via Benzinga GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 24, 2024 From GeneDx Holdings Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session January 12, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 10, 2024 Via Benzinga GeneDx Announces Preliminary 2023 Financial Results January 08, 2024 From GeneDx Holdings Corp. Via GlobeNewswire GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy December 01, 2023 New research from one of the largest exome sequencing studies of patients with epilepsy adds to the mounting evidence that exome sequencing offers superior clinical results compared to multi-gene... From GeneDx Holdings Corp. Via GlobeNewswire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.